Clinical Trial Update: SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug. [Phase 4]

View source ↗

Summary

This document reports that the Phase 4 SWITCH trial in rheumatoid arthritis patients who failed an initial TNF-blocking therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Julia Brown | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED